/ /

Vanessa Caceres
Why choosing the right multifocal IOL patients is important
The best candidates for multifocal intraocular lenses (IOLs) are highly motivated, have nearly perfect optics, and have healthy tear film. Otherwise, patients could have issues with contrast sensitivity, glare, and haloes.
Multiple next-generation stents lead to better IOP control
The use of multiple second-generation stent systems led to a 20% or higher reduction in IOP in a group of patients with mild-to-moderate, open-angle glaucoma.
New dual blade can help surgeons lower IOP
A new trabecular meshwork excision blade takes a new approach in IOP reduction.
Portable non-mydriatic device closes gap on tele-glaucoma screening
A portable non-mydriatic fundus camera was found useful in grading cup-to-disc ratio as part of glaucoma screening compared with a standard tabletop mydriatic fundus camera.
Combination therapy targets pupil maintenance, pain
The combination of phenylephrine and ketorolac helped maintain pupil diameter and lowered postoperative pain compared with placebo in patients having cataract surgery in two pooled phase III studies.
What ARMOR update means for ocular infections
Tailor antibiotic choices for each patient, as resistance remains high, according to the 2015 Antibiotic Resistance Monitoring in Ocular micRoorganisms (ARMOR) update.
Treating retinochoroiditis caused by toxomoplasis
Trimethoprim-sulfamethoxazole can be used both acutely and prophylactically in patients with Toxoplasma gondii retinochoroiditis.
Novel dual agonist leads to notable IOP lowering
The drug ONO-9054 led to a greater reduction in IOP and a longer duration of reduction in a small clinical trial compared with latanoprost.
Why infections related to PK require intense vigilance
The causes of infections associated with penetrating keratoplasty are evolving, but no matter what the etiology, these infections consistently require vigilance and aggressive treatment.
Gauging ganciclovir gel for herpes virus
Gauging ganciclovir gel for herpes virus
Ganciclovir gel is effective for herpes simplex epithelial keratitis, and emerging evidence shows it also can be used to treat other corneal disease.